Contineum Therapeutics (CTNM)

Contineum Therapeutics (CTNM) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CTNM last traded at $9.58, 2.02% on the day.
• Contineum Therapeutics: P/E -5.5.
• Over the past year CTNM returned -9.11%; year to date -16.19%.

Updated 2026-11-03 00:43 UTC